BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Thursday reported a fourth-quarter loss of $3.3 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Beverly Hills, California-based company said it had a loss of 11 cents.
The biotechnology company posted revenue of $648,100 in the period. Its adjusted revenue was $648,000.
For the year, the company reported a loss of $15.2 million, or 52 cents per share, swinging to a loss in the period. Revenue was reported as $1.7 million.
In the final minutes of trading on Thursday, the company's shares hit 56 cents. A year ago, they were trading at $1.28.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR